ABSTRACT
The alternative medicines are commonly used, especially herbal ones. Among them, boldo is traditionally used for symptomatic treatment of dyspepsia and mild gastrointestinal spasmodic disorders. Nevertheless, the number of reported cases of possible hepatotoxicity of some of these products has increased, including one report of boldo-induced hepatitis. We present the case of a 72-year-old female patient who has developed jaundice and increased serum levels of liver enzymes, after repeated consumption of boldo leaves infusion, during 2 weeks. After exclusion of common causes of hepatobiliary pathology, boldo-induced hepatotoxicity was considered probable. Interrupting of ingestion led to clinical and laboratorial recovery. This case proves the value of research in the alternative medicines' use. Ingestion of boldo, particularly in elderly patients with biliary tract disorders, may be the cause of otherwise unexplained jaundice or abnormal values of liver enzymes.
Subject(s)
Chemical and Drug Induced Liver Injury/complications , Complementary Therapies/adverse effects , Jaundice/chemically induced , Peumus/poisoning , Plant Leaves/poisoning , Aged , Female , HumansABSTRACT
Few biomarkers are available to predict prostate cancer risk. Single nucleotide polymorphisms (SNPs) tend to have weak individual effects but, in combination, they have stronger predictive value. Adipokine pathways have been implicated in the pathogenesis. We used a candidate pathway approach to investigate 29 functional SNPs in key genes from relevant adipokine pathways in a sample of 1006 men eligible for prostate biopsy. We used stepwise multivariate logistic regression and bootstrapping to develop a multilocus genetic risk score by weighting each risk SNP empirically based on its association with disease. Seven common functional polymorphisms were associated with overall and high-grade prostate cancer (Gleason≥7), whereas three variants were associated with high metastatic-risk prostate cancer (PSA≥20 ng/mL and/or Gleason≥8). The addition of genetic variants to age and PSA improved the predictive accuracy for overall and high-grade prostate cancer, using either the area under the receiver-operating characteristics curves (P<0.02), the net reclassification improvement (P<0.001) and integrated discrimination improvement (P<0.001) measures. These results suggest that functional polymorphisms in adipokine pathways may act individually and cumulatively to affect risk and severity of prostate cancer, supporting the influence of adipokine pathways in the pathogenesis of prostate cancer. Use of such adipokine multilocus genetic risk score can enhance the predictive value of PSA and age in estimating absolute risk, which supports further evaluation of its clinical significance.
Subject(s)
Adipokines/genetics , Adipokines/metabolism , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , Aged , Biopsy/methods , Case-Control Studies , Genetic Predisposition to Disease , Humans , Logistic Models , Male , Polymorphism, Single Nucleotide , Predictive Value of Tests , ROC Curve , Signal TransductionABSTRACT
BACKGROUND/AIMS: The microenvironment produces important factors that are crucial to prostate cancer (PCa) progression. However, the extent to which the cancer cells stimulate periprostatic adipose tissue (PPAT) to produce these proteins is largely unknown. Our purpose was to determine whether PCa cell-derived factors influence PPAT metabolic activity. METHODS: Primary cultures of human PPAT samples from PCa patients (adipose tissue organotypic explants and primary stromal vascular fraction, SVF) were stimulated with conditioned medium (CM) collected from prostate carcinoma (PC3) cells. Cultures without CM were used as control. We used multiplex analysis and ELISA for protein quantification, qPCR to determine mitochondrial DNA (mtDNA) copy number and zymography for matrix metalloproteinase activity, in order to evaluate the response of adipose tissue explants and SVFs to PC3 CM. RESULTS: Stimulation of PPAT explants with PCa PC3 CM induced adipokines associated with cancer progression (osteopontin, tumoral necrosis factor alpha and interleukin-6) and reduced the expression of the protective adipokine adiponectin. Notably, osteopontin protein expression was 13-fold upregulated. Matrix metalloproteinase 9 activity and mitochondrial DNA copy number were higher after stimulation with cancer CM. Stromovascular cells from PPAT in culture were not influenced by tumor-derived factors. CONCLUSION: The modulation of adipokine expression by tumor CM indicates the pervasive extent to which tumor cells command PPAT to produce factors favorable to their aggressiveness.
